Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-23-000369
Filing Date
2023-01-25
Accepted
2023-01-25 15:45:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 COWEN FINANCIAL PRODUCTS LLC stoka1_12523.htm SC 13G/A 25739
  Complete submission text file 0001085146-23-000369.txt   27272
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Subject) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91051 | Film No.: 23552428
SIC: 2834 Pharmaceutical Preparations

Mailing Address 599 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 599 LEXINGTON AVENUE NEW YORK NY 10022 6465621000
Cowen Financial Products LLC (Filed by) CIK: 0001771015 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A